Table 3 Treatment-related adverse events experienced by ≥ 20% patients
Adverse event | All grades n (%) | Gr 2, n (%) | Gr 3, n (%) | Gr 4, n (%) |
|---|---|---|---|---|
Elevated ALT | 6 (42.9) | 1 (7.1) | 0 (0.0) | 0 (0.0) |
Elevated AST | 5 (35.7) | 1 (7.1) | 1 (7.1) | 0 (0.0) |
Lipase increased | 5 (35.7) | 2 (14.3) | 1 (7.1) | 1 (7.1) |
Fatigue | 4 (28.6) | 2 (14.2) | 1 (7.1) | 0 (0.0) |
Diarrhea | 3 (21.4) | 1 (7.1) | 0 (0.0) | 0 (0.0) |
Lymphocyte count decreased | 3 (21.4) | 2 (14.3) | 0 (0.0) | 0 (0.0) |
Nausea | 3 (21.4) | 3 (21.4) | 0 (0.0) | 0 (0.0) |
Platelet count decreased | 3 (21.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) |